期刊文献+

促泌素在胃肠道神经内分泌肿瘤中的表达及其临床意义 被引量:6

Expression and significance of secretagogin in gastrointestinal neuroendocrine tumors
在线阅读 下载PDF
导出
摘要 目的比较促泌素(secretagogin,SCGN)与传统的神经内分泌标记物在胃肠道神经内分泌肿瘤中的表达差异。方法收集胃肠道手术标本共88例,其中实验组为8例类癌和20例非典型类癌,对照组为40例腺癌伴神经内分泌分化和20例腺癌。所有标本均使用SCGN、PGP9.5、CD56、NSE、Syn及CgA进行免疫组织化学SP两步法染色。结果 SCGN可在胃肠道粘膜固有层腺体的弥散性神经内分泌细胞中表达,多显示"开放型"的神经内分泌细胞。除CD56和NSE各在1例胃肠道腺癌中阳性表达外,SCGN及其它标记物在20例腺癌中均无表达,所有标记物之间均无统计学差异(P>0.05)。SCGN在40例胃肠道腺癌伴神经内分泌分化、20例非典型类癌和8例类癌中的阳性表达率均最高,分别为62.5%(25/40)、90%(18/20)和100%(8/8),PGP9.5阳性表达率均最低分别为32.5%(13/40)、45%(9/20)和37.5%(3/8),两标记物在这三组肿瘤中的表达均有显著统计学差异(P<0.01),而CD56、NSE、Syn和CgA在以上三组肿瘤中的表达率均较高,与SCGN比较均无统计学差异(P>0.05)。所有标记物在腺癌伴神经内分泌分化、非典型类癌和类癌中的阳性表达率均明显高于腺癌(P<0.01);SCGN、Syn和CgA在非典型类癌和类癌中的阳性表达均高于腺癌伴神经内分泌分化(P<0.05);所有标记物在非典型类癌和类癌之间的阳性表达率均无统计学差异(P>0.05)。结论 SCGN作为一种新型的神经内分泌标记物与传统标记物Syn和CgA联合,可应用于胃肠道神经内分泌肿瘤的临床病理诊断。 Objective To investigate the different expressions between secretagogin(SCGN) and traditional neuroendocrine markers in gastrointestinal neuroendocrine tumors. Methods Eighty-eight samples of gastrointestinal tumors were collected,including 8 carcinoid and 20 atypical carcinoid cases in the experimental group;40 adenocarcinoma with focal neuroendocrine differentiation and 20 adenocarcinoma as the control group.All specimens were detected by streptavidin-peroxidase two-step immunohistochemical method.For SCGN and 5 conventional neuroendocrine markers PGP9.5,CD56,NSE,Syn and CgA. Results SCGN showed positive staining in neuroendocrine cells of the lamina propria gland in normal gastrointestinal mucosa.Most SCGN expression was in the so called "open" neuroendocrine cells.CD56 and NSE were each positive in one of adenocarcinomas,while SCGN,PGP9.5,Syn and CgA were negative in all adenocarcinomas.The expression of all markers in adenocarcinomas had no statistical significance(P0.05).The positive rates of SCGN were the highest in 25 of 40(62.5%) adenocarcinomas with focal neuroendocrine differentiation,18 of 20(90%) atypical carcinoids and 8 of 8(100%) carcinoids,which were obviously different from those of PGP9.5(32.5%,45% and 37.5%,respectively)(P0.01).Meanwhile,the positive rates of CD56,NSE,Syn and CgA were similar to those of SCGN,with no significant differences(P0.05).The positive rates of all markers in adenocarcinomas with focal neuroendocrine differentiation,atypical carcinoids and carcinoids were significantly higher than those in adenocarcinomas(P0.01,respectively).The expressions of SCGN,Syn and CgA in atypical carcinoid and carcinoid were higher than those in adenocarcinomas with focal neuroendocrine differentiation(P0.05,respectively).However,the positive rates of all markers had no significant differences between atypicalcarcinoid and carcinoid(P0.05). Conclusion SCGN is a novel neuroendocrine marker.A combination of SCGN,Syn and CgA could serve as pathological diagnostic markers for gastrointestinal neuroendocrine tumors.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2012年第2期186-191,共6页 Chinese Journal of Histochemistry and Cytochemistry
关键词 促泌素 神经内分泌肿瘤 胃肠道 免疫组织化学 Secretagogin Neuroendocrine tumors Gastrointestinal tract Immunohistochemistry
  • 相关文献

参考文献13

  • 1Wagner L,Tempi E,Reining G. Culture of human insulinoma cells:development of a neuroendocrinte tumour cell-and human pancreatic islet cell-specific monoclonal antibody[J].Endocrinology,1998,(03):469-476.
  • 2Wagner L,Oliyarnyk O,Gartner W. Cloning and expression of secretagogin,a novel neuroendocrine and pancreatic islet of Langerhans-specific Ca2+-binding protein[J].Biological Chemistry,2000,(32):24740-24751.
  • 3于萍,步宏,王华,赵高平,张景丽,周桥.免疫组化结果的图像分析与人工计数方法的对比研究[J].生物医学工程学杂志,2003,20(2):288-290. 被引量:188
  • 4Lai MD,Lu BJ,Xing XM. Secretagogin is a novel neuroendocrine marker,has a distinct expression pattern from chromogranin A[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2006,(04):402-409.
  • 5林万润,刘雯,马金龙,刘署亮,葛兴平,桂婷,秦小敏,周庚寅.Secretagogin在神经内分泌肿瘤组织的表达[J].中国现代普通外科进展,2009,12(6):481-484. 被引量:7
  • 6Rogstam A,Linse S,Lindqvist A. Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin[J].Biochemical Journal,2007,(01):353-363.
  • 7Bauer MC,O'Connell DJ,Maj M. Identification of a high-affinity network of secretagogin-binding proteins involved in vesicle secretion[J].Mol Bioayst,2011,(07):2196-2204.
  • 8Hamilton SR,Aaltonen LA. World Health Organization Classification of tumours,Pathology and Genetics of Tumouts of the Digestive System[M].Lyon:iarc Press,2000.53-58.
  • 9Volante M,Rindi G,Papotti M. The grey zone between pure (neuro) endocrine and non-(neuro) endocrine tumours:a comment on concepts and classification of mixed exocrine-endocrine neoplasms[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2006,(05):499-506.
  • 10Yamashita K,Park HL,Kim MS. PGP9.5 methylation in diffuse-type gastric cancer[J].Cancer Research,2006,(07):3921-3927.

二级参考文献19

  • 1朱爱萍,张青云,王雅明,徐建军.人神经元特异性烯醇化酶基因克隆及单克隆抗体的制备与鉴定[J].中华检验医学杂志,2005,28(2):197-199. 被引量:5
  • 2Modlin IM.Lye KD,Kidd MA.5-decade analysis of 13715 carcinoid tumors[J].Cancer,2003,97(4):934-959.
  • 3Taupenot L,Harper KL O'Connor DT.The chromograninsecretogranin family[J].N Engl J Med,2003,348(12):1134-1149.
  • 4Wagner L,Templ E,Reining G,et al.Culture of human insulinoma cells:development of a neuroendoerine tumour cell-and humanpancreatic islet cell-specific monoelonal antibody[J].Endocrinol,1998,156(3):469-476.
  • 5Berggard T,Miron S,Onnerfjord P,et al.Calbindin D28k exhibits properties characteristic of 50172 practolol Ca2+ sensor[J].Biol Chem,2002,277(19):16662-16672.
  • 6Pipp I,Wagner L R6sslcr K,et al.Secretagogin expression in tumours of the human brain and its coverings[J].APMIS,2007,115 (4):319-326.
  • 7Attems J,Preusser M,Grosinger-Quass M,et al.Calcium-binding protein seeretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease[J].Neuropathol Appl Neurobiol,2008,34(1):23-32.
  • 8Cras-Meneur C,Inoue H,Zhou Y,et al.An expression profile of human pancreatic islet mRNAs by serial analysis of gene expression (SAGE)[J].Diabetologia,2004,47(2):284-299.
  • 9Maode Lai,Bingjian Lü,Xiaoming Xing,et al.Secretagogin,a novel neuroendocrine marker,has a distinct.expression pattern from chromogranin A[J].Virchows Arch,2006,449(4):402-409.
  • 10Guinee DG Jr,Fishback NF,Koss MN,et al.The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbmnchial andopen-lung biopsies.Am[J].Clin Pathol,1994,102(4):406-414.

共引文献203

同被引文献52

  • 1陈建华,欧阳玉林,朱文彪,彭静.肿瘤标志物癌胚抗原(CEA)检测在非小细胞肺癌诊治中的临床意义[J].现代肿瘤医学,2005,13(2):199-200. 被引量:30
  • 2张青云,徐建军,王雅明.人神经元特异性烯醇化酶在肿瘤细胞系中的表达检测及意义[J].中华检验医学杂志,2005,28(7):728-731. 被引量:12
  • 3贺量,冷波,康劲翮,陈清西.胃癌细胞SGC-7901双向电泳系统的建立及优化[J].厦门大学学报(自然科学版),2006,45(B05):149-151. 被引量:8
  • 4Fan LF,Diao LM,Chen DJ,et al.Expression of HIF-1alpha and itsrelationship to apoptosis and proliferationin lung cancer[J].Ai Zheng,2002,21:254-258.
  • 5Batcher E, Madaj P,Gianoukakis AG, et al. Pancreaticneuroendocrine tumors [J]. Endocr Res,2011,36 (1) : 35-.
  • 6Delaunoit T, Neczyporenko F, Rubin J, et al. Medicalmanagement of pancreatic neuroendocrine tumors [ JAm J Gastroenterol?2008,103(2) :475-483.
  • 7Sheth S> Hruban RK,Fishman EK. Helical CT of isletcell tumors of the pancreas: typical and atypical manifes-tations[J]. Am J Roentgenol,2002,179 :725.
  • 8陈原稼.胰腺内分泌肿瘤发病机理和预后[C].中华医学会消化病学分会——2005年全国胃肠激素学术研讨会论文集,2005:33.
  • 9O'Grady H, Conlon K. Pancreatic neuroendocrine tumours[J]. Europ J Surg Oncolf 2008?34 :324.
  • 10乔新伟,陈原稼,邱玲,等.胰腺神经内分泌肿瘤病人手术前后以及术后复发时血清铬粒素A的变化[C]. 2012中国消化病学大会,2012:188-189.

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部